Norman S. Miller

2 papers in the library · 156 citations · publishing 1997-2025

Papers

MDMA (Ecstasy) and the Rave: A Review

Pediatrics October 1, 1997 Richard H. Schwartz, Norman S. Miller 155 citations

MDMA (ecstasy) is a designer drug popular among American adolescents at raves and on college campuses, with an undeserved reputation for safety. Short-term effects include sweating, tachycardia, fatigue, and muscle spasms; serious adverse effects include fatal heat injury, fluid and electrolyte depletion, and dysfunction of the central nervous system, heart, muscles, kidneys, and liver. MDMA has been implicated in at least 53 deaths in the United Kingdom and at least five in the United States, mainly from heatstroke. It is a selective serotonergic neurotoxin. Toxicology screening tests detect MDMA with about 50% reduced sensitivity. Treatment of acute toxicity involves rapid cooling, rehydration, and monitoring electrolytes and organ function.

DOI: 10.1542/peds.100.4.705 Ecstasy MDMA Medicine Psychiatry

Psychedelics: Safety and Efficacy.

Int J Environ Res Public Health January 21, 2025 Norman S. Miller 1 citation

Despite a recent surge in psychedelic research and institutional support, most studies lack scientific rigor and focus on safety and efficacy. Many published studies are poorly designed, and misleading information is common. The current Schedule I classification—indicating no medical value and high abuse potential—complicates research. This paper argues that personal and financial biases further undermine the field, and it calls attention to the neglected literature on safety, adverse effects, and the history of psychedelic use.

DOI: 10.3390/ijerph22020134 Full text Psychedelic therapy Mental health treatment Clinical research Psychiatric medicine +1